BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di Fiore R, Suleiman S, Ellul B, O'Toole SA, Savona-Ventura C, Felix A, Napolioni V, Conlon NT, Kahramanoglu I, Azzopardi MJ, Dalmas M, Calleja N, Brincat MR, Muscat-Baron Y, Sabol M, Dimitrievska V, Yordanov A, Vasileva-Slaveva M, von Brockdorff K, Micallef RA, Kubelac P, Achimaș-Cadariu P, Vlad C, Tzortzatou O, Poka R, Giordano A, Felice A, Reed N, Herrington CS, Faraggi D, Calleja-Agius J. GYNOCARE Update: Modern Strategies to Improve Diagnosis and Treatment of Rare Gynecologic Tumors—Current Challenges and Future Directions. Cancers (Basel) 2021;13:493. [PMID: 33514073 DOI: 10.3390/cancers13030493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Zhu X, Wang L, Chen Y, Chen R, Zheng Z, Yang H, Xia W, Yao J, Zhao K. Identification of Tumor Suppressor Gene LHPP-Based 5-microRNA Signature That Predicts the Early- and Midstage Esophageal Squamous Cell Carcinoma: A Two-Stage Case-Control Study in the Chinese Han Population. Laboratory Medicine 2022. [DOI: 10.1093/labmed/lmac125] [Reference Citation Analysis]
2 Farzaneh M, Najafi S, Dari MAG, Sheykhi-Sabzehpoush M, Dayer D, Cheraghzadeh M, Azizidoost S. Functional roles of long noncoding RNA MALAT1 in gynecologic cancers. Clin Transl Oncol 2022. [PMID: 36042115 DOI: 10.1007/s12094-022-02914-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Daviu C, Blaakaer J, Eriksson AGZ, Herrstedt J, Vandborg MP, Rasmussen AMO, Fuglsang K. Nonepithelial ovarian cancer – the current clinical practice in the Nordic countries. Survey from the surgical subcommittee of the Nordic society of gynecological oncology (NSGO). Acta Oncologica. [DOI: 10.1080/0284186x.2022.2088249] [Reference Citation Analysis]
4 Idlahcen F, Idri A. Systematic Map of Data Mining for Gynecologic Oncology. Information Systems and Technologies 2022. [DOI: 10.1007/978-3-031-04826-5_47] [Reference Citation Analysis]
5 Ashley S, Shilhan D, Battye M, Meyer C, Mancini M, Ayres B, Muneer A, Albersen M, Feitz W, Langenhuijsen JF, Sangar V. Clinical performance in ERN eUROGEN for penile, testicular, adrenal and soft tissue cancers. Eur J Surg Oncol 2021:S0748-7983(21)00819-2. [PMID: 34893364 DOI: 10.1016/j.ejso.2021.11.014] [Reference Citation Analysis]
6 Subbannayya Y, Di Fiore R, Urru SAM, Calleja-Agius J. The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives. Biomedicines 2021;9:1481. [PMID: 34680597 DOI: 10.3390/biomedicines9101481] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Sabol M, Calleja-Agius J, Di Fiore R, Suleiman S, Ozcan S, Ward MP, Ozretić P. (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers. Cancers (Basel) 2021;13:5040. [PMID: 34680193 DOI: 10.3390/cancers13205040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Di Fiore R, Suleiman S, Drago-Ferrante R, Felix A, O'Toole SA, O'Leary JJ, Ward MP, Beirne J, Yordanov A, Vasileva-Slaveva M, Subbannayya Y, Pentimalli F, Giordano A, Calleja-Agius J. LncRNA MORT (ZNF667-AS1) in Cancer-Is There a Possible Role in Gynecological Malignancies? Int J Mol Sci 2021;22:7829. [PMID: 34360598 DOI: 10.3390/ijms22157829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Scicchitano P, Tucci M, Ricci G, Gesualdo M, Carbonara S, Totaro G, Cecere A, Carbonara R, Cortese F, Loizzi V, Cormio G, Cicinelli E, Ciccone MM. Vascular and Cardiac Prognostic Determinants in Patients with Gynecological Cancers: A Six-Year Follow-up Study. Applied Sciences 2021;11:6091. [DOI: 10.3390/app11136091] [Reference Citation Analysis]
10 Di Fiore R, Suleiman S, Pentimalli F, O'Toole SA, O'Leary JJ, Ward MP, Conlon NT, Sabol M, Ozretić P, Erson-Bensan AE, Reed N, Giordano A, Herrington CS, Calleja-Agius J. Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview. Int J Mol Sci 2021;22:3822. [PMID: 33917022 DOI: 10.3390/ijms22083822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Nair M, Brudie LA, Mudgapalli VV, Gayathri V, Chandra A, Ahmad S, Basha R. Current treatment modalities in major gynecologic cancers: Emphasis on response rates. Overcoming Drug Resistance in Gynecologic Cancers 2021. [DOI: 10.1016/b978-0-12-824299-5.00020-4] [Reference Citation Analysis]